Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Growth 2025-2031

December 2025 | 95 pages | ID: GC13B72A43EAEN
LP Information

Abstracts

The global Oral Solid Dosage Forms (OSDF) and Pharma Excipients market size is predicted to grow from US$ 894 million in 2025 to US$ 1168 million in 2031; it is expected to grow at a CAGR of 4.6% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Oral Solid Dosage Forms (OSDF) and Pharma Excipients is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Oral Solid Dosage Forms (OSDF) and Pharma Excipients is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Oral Solid Dosage Forms (OSDF) and Pharma Excipients is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Oral Solid Dosage Forms (OSDF) and Pharma Excipients players cover ABITEC Corporation, AkzoNobel, Archer Daniels Midland (ADM), BASF, DowDuPont, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Oral Solid Dosage Forms (OSDF) and Pharma Excipients Industry Forecast” looks at past sales and reviews total world Oral Solid Dosage Forms (OSDF) and Pharma Excipients sales in 2024, providing a comprehensive analysis by region and market sector of projected Oral Solid Dosage Forms (OSDF) and Pharma Excipients sales for 2025 through 2031. With Oral Solid Dosage Forms (OSDF) and Pharma Excipients sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Solid Dosage Forms (OSDF) and Pharma Excipients industry.

This Insight Report provides a comprehensive analysis of the global Oral Solid Dosage Forms (OSDF) and Pharma Excipients landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Solid Dosage Forms (OSDF) and Pharma Excipients portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral Solid Dosage Forms (OSDF) and Pharma Excipients market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Solid Dosage Forms (OSDF) and Pharma Excipients and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Solid Dosage Forms (OSDF) and Pharma Excipients.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Solid Dosage Forms (OSDF) and Pharma Excipients market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Glycerin
• Propylene Glycol
• Sorbitol
• Mannitol
• Others

Segmentation by Application:

• Industrial Application
• Non-industrial Application

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• ABITEC Corporation
• AkzoNobel
• Archer Daniels Midland (ADM)
• BASF
• DowDuPont
• Evonik
• J.M. Huber Corporation
• Cargill
• Eastman Chemical Company

Key Questions Addressed in this Report

What is the 10-year outlook for the global Oral Solid Dosage Forms (OSDF) and Pharma Excipients market?

What factors are driving Oral Solid Dosage Forms (OSDF) and Pharma Excipients market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Oral Solid Dosage Forms (OSDF) and Pharma Excipients market opportunities vary by end market size?

How does Oral Solid Dosage Forms (OSDF) and Pharma Excipients break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Country/Region, 2020, 2024 & 2031
2.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Segment by Type
  2.2.1 Glycerin
  2.2.2 Propylene Glycol
  2.2.3 Sorbitol
  2.2.4 Mannitol
  2.2.5 Others
2.3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type
  2.3.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Type (2020-2025)
  2.3.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sale Price by Type (2020-2025)
2.4 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Segment by Application
  2.4.1 Industrial Application
  2.4.2 Non-industrial Application
2.5 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application
  2.5.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sale Market Share by Application (2020-2025)
  2.5.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Breakdown Data by Company
  3.1.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Annual Sales by Company (2020-2025)
  3.1.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Company (2020-2025)
3.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Annual Revenue by Company (2020-2025)
  3.2.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Company (2020-2025)
  3.2.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Company (2020-2025)
3.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sale Price by Company
3.4 Key Manufacturers Oral Solid Dosage Forms (OSDF) and Pharma Excipients Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Location Distribution
  3.4.2 Players Oral Solid Dosage Forms (OSDF) and Pharma Excipients Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ORAL SOLID DOSAGE FORMS (OSDF) AND PHARMA EXCIPIENTS BY GEOGRAPHIC REGION

4.1 World Historic Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Geographic Region (2020-2025)
  4.1.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Country/Region (2020-2025)
  4.2.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth
4.4 APAC Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth
4.5 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth
4.6 Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth

5 AMERICAS

5.1 Americas Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country
  5.1.1 Americas Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2020-2025)
  5.1.2 Americas Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2020-2025)
5.2 Americas Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2020-2025)
5.3 Americas Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Region
  6.1.1 APAC Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Region (2020-2025)
  6.1.2 APAC Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Region (2020-2025)
6.2 APAC Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2020-2025)
6.3 APAC Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Country
  7.1.1 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2020-2025)
  7.1.2 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2020-2025)
7.2 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2020-2025)
7.3 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Country
  8.1.1 Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2020-2025)
8.2 Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2020-2025)
8.3 Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Solid Dosage Forms (OSDF) and Pharma Excipients
10.3 Manufacturing Process Analysis of Oral Solid Dosage Forms (OSDF) and Pharma Excipients
10.4 Industry Chain Structure of Oral Solid Dosage Forms (OSDF) and Pharma Excipients

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Distributors
11.3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Customer

12 WORLD FORECAST REVIEW FOR ORAL SOLID DOSAGE FORMS (OSDF) AND PHARMA EXCIPIENTS BY GEOGRAPHIC REGION

12.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Forecast by Region
  12.1.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Forecast by Region (2026-2031)
  12.1.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Forecast by Type (2026-2031)
12.7 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 ABITEC Corporation
  13.1.1 ABITEC Corporation Company Information
  13.1.2 ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Portfolios and Specifications
  13.1.3 ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 ABITEC Corporation Main Business Overview
  13.1.5 ABITEC Corporation Latest Developments
13.2 AkzoNobel
  13.2.1 AkzoNobel Company Information
  13.2.2 AkzoNobel Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Portfolios and Specifications
  13.2.3 AkzoNobel Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 AkzoNobel Main Business Overview
  13.2.5 AkzoNobel Latest Developments
13.3 Archer Daniels Midland (ADM)
  13.3.1 Archer Daniels Midland (ADM) Company Information
  13.3.2 Archer Daniels Midland (ADM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Portfolios and Specifications
  13.3.3 Archer Daniels Midland (ADM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Archer Daniels Midland (ADM) Main Business Overview
  13.3.5 Archer Daniels Midland (ADM) Latest Developments
13.4 BASF
  13.4.1 BASF Company Information
  13.4.2 BASF Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Portfolios and Specifications
  13.4.3 BASF Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 BASF Main Business Overview
  13.4.5 BASF Latest Developments
13.5 DowDuPont
  13.5.1 DowDuPont Company Information
  13.5.2 DowDuPont Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Portfolios and Specifications
  13.5.3 DowDuPont Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 DowDuPont Main Business Overview
  13.5.5 DowDuPont Latest Developments
13.6 Evonik
  13.6.1 Evonik Company Information
  13.6.2 Evonik Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Portfolios and Specifications
  13.6.3 Evonik Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Evonik Main Business Overview
  13.6.5 Evonik Latest Developments
13.7 J.M. Huber Corporation
  13.7.1 J.M. Huber Corporation Company Information
  13.7.2 J.M. Huber Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Portfolios and Specifications
  13.7.3 J.M. Huber Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 J.M. Huber Corporation Main Business Overview
  13.7.5 J.M. Huber Corporation Latest Developments
13.8 Cargill
  13.8.1 Cargill Company Information
  13.8.2 Cargill Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Portfolios and Specifications
  13.8.3 Cargill Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Cargill Main Business Overview
  13.8.5 Cargill Latest Developments
13.9 Eastman Chemical Company
  13.9.1 Eastman Chemical Company Company Information
  13.9.2 Eastman Chemical Company Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Portfolios and Specifications
  13.9.3 Eastman Chemical Company Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Eastman Chemical Company Main Business Overview
  13.9.5 Eastman Chemical Company Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Glycerin
Table 4. Major Players of Propylene Glycol
Table 5. Major Players of Sorbitol
Table 6. Major Players of Mannitol
Table 7. Major Players of Others
Table 8. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2020-2025) & (K Units)
Table 9. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Type (2020-2025)
Table 10. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2020-2025) & ($ million)
Table 11. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Type (2020-2025)
Table 12. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sale Price by Type (2020-2025) & (USD/Unit)
Table 13. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sale by Application (2020-2025) & (K Units)
Table 14. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sale Market Share by Application (2020-2025)
Table 15. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2020-2025) & ($ million)
Table 16. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Application (2020-2025)
Table 17. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sale Price by Application (2020-2025) & (USD/Unit)
Table 18. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Company (2020-2025) & (K Units)
Table 19. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Company (2020-2025)
Table 20. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Company (2020-2025)
Table 22. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sale Price by Company (2020-2025) & (USD/Unit)
Table 23. Key Manufacturers Oral Solid Dosage Forms (OSDF) and Pharma Excipients Producing Area Distribution and Sales Area
Table 24. Players Oral Solid Dosage Forms (OSDF) and Pharma Excipients Products Offered
Table 25. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Geographic Region (2020-2025) & (K Units)
Table 29. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share Geographic Region (2020-2025)
Table 30. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country/Region (2020-2025) & (K Units)
Table 33. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Country/Region (2020-2025)
Table 34. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2020-2025) & (K Units)
Table 37. Americas Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Country (2020-2025)
Table 38. Americas Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2020-2025) & (K Units)
Table 40. Americas Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2020-2025) & (K Units)
Table 41. APAC Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Region (2020-2025) & (K Units)
Table 42. APAC Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Region (2020-2025)
Table 43. APAC Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2020-2025) & (K Units)
Table 45. APAC Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2020-2025) & (K Units)
Table 46. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2020-2025) & (K Units)
Table 47. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2020-2025) & (K Units)
Table 49. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2020-2025) & (K Units)
Table 50. Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2020-2025) & (K Units)
Table 51. Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2020-2025) & (K Units)
Table 53. Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2020-2025) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Oral Solid Dosage Forms (OSDF) and Pharma Excipients
Table 55. Key Market Challenges & Risks of Oral Solid Dosage Forms (OSDF) and Pharma Excipients
Table 56. Key Industry Trends of Oral Solid Dosage Forms (OSDF) and Pharma Excipients
Table 57. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Distributors List
Table 60. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Customer List
Table 61. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast by Region (2026-2031) & (K Units)
Table 62. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast by Country (2026-2031) & (K Units)
Table 64. Americas Oral Solid Dosage Forms (OSDF) and Pharma Excipients Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast by Region (2026-2031) & (K Units)
Table 66. APAC Oral Solid Dosage Forms (OSDF) and Pharma Excipients Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast by Country (2026-2031) & (K Units)
Table 70. Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast by Type (2026-2031) & (K Units)
Table 72. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast by Application (2026-2031) & (K Units)
Table 74. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. ABITEC Corporation Basic Information, Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturing Base, Sales Area and Its Competitors
Table 76. ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Portfolios and Specifications
Table 77. ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. ABITEC Corporation Main Business
Table 79. ABITEC Corporation Latest Developments
Table 80. AkzoNobel Basic Information, Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturing Base, Sales Area and Its Competitors
Table 81. AkzoNobel Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Portfolios and Specifications
Table 82. AkzoNobel Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. AkzoNobel Main Business
Table 84. AkzoNobel Latest Developments
Table 85. Archer Daniels Midland (ADM) Basic Information, Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturing Base, Sales Area and Its Competitors
Table 86. Archer Daniels Midland (ADM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Portfolios and Specifications
Table 87. Archer Daniels Midland (ADM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Archer Daniels Midland (ADM) Main Business
Table 89. Archer Daniels Midland (ADM) Latest Developments
Table 90. BASF Basic Information, Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturing Base, Sales Area and Its Competitors
Table 91. BASF Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Portfolios and Specifications
Table 92. BASF Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. BASF Main Business
Table 94. BASF Latest Developments
Table 95. DowDuPont Basic Information, Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturing Base, Sales Area and Its Competitors
Table 96. DowDuPont Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Portfolios and Specifications
Table 97. DowDuPont Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. DowDuPont Main Business
Table 99. DowDuPont Latest Developments
Table 100. Evonik Basic Information, Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturing Base, Sales Area and Its Competitors
Table 101. Evonik Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Portfolios and Specifications
Table 102. Evonik Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Evonik Main Business
Table 104. Evonik Latest Developments
Table 105. J.M. Huber Corporation Basic Information, Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturing Base, Sales Area and Its Competitors
Table 106. J.M. Huber Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Portfolios and Specifications
Table 107. J.M. Huber Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. J.M. Huber Corporation Main Business
Table 109. J.M. Huber Corporation Latest Developments
Table 110. Cargill Basic Information, Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturing Base, Sales Area and Its Competitors
Table 111. Cargill Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Portfolios and Specifications
Table 112. Cargill Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Cargill Main Business
Table 114. Cargill Latest Developments
Table 115. Eastman Chemical Company Basic Information, Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturing Base, Sales Area and Its Competitors
Table 116. Eastman Chemical Company Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Portfolios and Specifications
Table 117. Eastman Chemical Company Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Eastman Chemical Company Main Business
Table 119. Eastman Chemical Company Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Oral Solid Dosage Forms (OSDF) and Pharma Excipients
Figure 2. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Country/Region (2024)
Figure 10. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Glycerin
Figure 12. Product Picture of Propylene Glycol
Figure 13. Product Picture of Sorbitol
Figure 14. Product Picture of Mannitol
Figure 15. Product Picture of Others
Figure 16. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Type in 2025
Figure 17. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Type (2020-2025)
Figure 18. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumed in Industrial Application
Figure 19. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market: Industrial Application (2020-2025) & (K Units)
Figure 20. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Consumed in Non-industrial Application
Figure 21. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market: Non-industrial Application (2020-2025) & (K Units)
Figure 22. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sale Market Share by Application (2024)
Figure 23. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Application in 2025
Figure 24. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Company in 2025 (K Units)
Figure 25. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Company in 2025
Figure 26. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Company in 2025 ($ millions)
Figure 27. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Company in 2025
Figure 28. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales 2020-2025 (K Units)
Figure 31. Americas Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue 2020-2025 ($ millions)
Figure 32. APAC Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales 2020-2025 (K Units)
Figure 33. APAC Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue 2020-2025 ($ millions)
Figure 34. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales 2020-2025 (K Units)
Figure 35. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales 2020-2025 (K Units)
Figure 37. Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue 2020-2025 ($ millions)
Figure 38. Americas Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Country in 2025
Figure 39. Americas Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Country (2020-2025)
Figure 40. Americas Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Type (2020-2025)
Figure 41. Americas Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Application (2020-2025)
Figure 42. United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Region in 2025
Figure 47. APAC Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Region (2020-2025)
Figure 48. APAC Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Type (2020-2025)
Figure 49. APAC Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Application (2020-2025)
Figure 50. China Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth 2020-2025 ($ millions)
Figure 54. India Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Country in 2025
Figure 58. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Country (2020-2025)
Figure 59. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Type (2020-2025)
Figure 60. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Application (2020-2025)
Figure 61. Germany Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth 2020-2025 ($ millions)
Figure 62. France Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Application (2020-2025)
Figure 69. Egypt Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Oral Solid Dosage Forms (OSDF) and Pharma Excipients in 2025
Figure 75. Manufacturing Process Analysis of Oral Solid Dosage Forms (OSDF) and Pharma Excipients
Figure 76. Industry Chain Structure of Oral Solid Dosage Forms (OSDF) and Pharma Excipients
Figure 77. Channels of Distribution
Figure 78. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Forecast by Region (2026-2031)
Figure 79. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share Forecast by Application (2026-2031)